This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
“We appreciate the American Medical Association’s decision to assign FFRCT a Category I CPT code, a decision backed by years of research that highlights the positive impact FFRCT can have on the diagnosis and eventually treatment of patients with coronary artery disease,” said John Farquhar , CEO of HeartFlow.
Cardiac CTs Rise Its clear the cardiology industry is warming up to cardiac imaging as imaging OEMs released cheaper specialized cardiac CTs to meet growing demand as a result of encouraging reimbursement changes. Reimbursement is Key A common question asked at ACC.25 25 was How do I get reimbursed?
Cardiac PET Industry Coalition CPIC passionately advocates for and protects the reimbursement of Cardiac PET, ensuring equitable access to innovative and life-saving technologies for healthcare providers and patients. For more information: www.positron.com If you enjoy this content, please share it with a colleague
Concerns have emerged about the declining academic research opportunities during EP fellowship training and its impact on career trajectories. Moreover, the increasing emphasis on clinical productivity for reimbursements may deter some from pursuing research.
Challenges also exist in developing a strategy at the practice level for implementing an RPM program, including reimbursement options and device integration into the clinician workflow. Surveys have shown clinicians are looking to professional medical societies to provide guidance on the optimal use of direct-to-consumer devices.
The rapid pace of innovation in EP may be hindered by several challenges including the aging population with increasing morbidity, the availability of multiple costly therapies that, in many instances, confer minor incremental benefit, the limitations of healthcare reimbursement, the lack of response to therapies by some patients, and the complications (..)
An international research team used Us2.ai’s with HFpEF) That last part is notable from an echo AI adoption perspective, given that CMS recently approved an outpatient reimbursement code for AI-based HFpEF detection ($285 per use) It could also prove to be notable for Us2.ai, The post Us2.ai’s
Introduction:Pediatric stroke research is hindered by lack of funding and relative disease rarity. Shared data in pediatric stroke is done via non-reimbursed data input by clinical investigators at participating childrens hospitals with the International Pediatric Stroke Study (IPSS).
Interdisciplinary Training and Education Cross-specialty rotations for medical professionals Joint continuing education sessions Simulation-based training for complex case management 5.
His industry roles have included serving as Chief Medical Officer for HLT Medical, a transcatheter heart valve company, as Chief of Cardiology with Optum/United Health subsidiary SCA Health, and as Medical Director for clinical research organization Medpace.
Marco Mazzanti , Scientific Director of International Research Frameworks on Artificial Intelligence in Cardiology, notes, “Pharmacies often serve as accessible points of care for many patients. Integrating AI-powered ECG analysis into these networks can enhance patient care.
Latest research in Renal Denervation The Paradise by Recor Medical How does Paradise renal denervation work? Dr. Kirtane echoes concerns about reimbursement, anticipating a potential impediment initially. This process effectively reduces the hyperactivity of the sympathetic nerves, leading to a decrease in blood pressure.
Getting Started with National Data Registries Healthcare institutions must participate and engage in the national data registries as it plays a significant role in advancing care and research. The below-given table will help you understand the purpose and uses of data registries more explicitly.
Gemms EHR simplifies medical billing with automated processes, reducing errors and ensuring timely reimbursements. This involves staying informed about the latest research and best practices in cardiology. Speedy and Efficient Medical Billing Efficient billing processes are crucial for a clinic’s financial health.
We weave together everything from the CMIO, to the nurse practitioners to the IT experts to the individuals who are doing research, analytics and infrastructure support. It’s one of the strengths of why people come to HIMSS.
The buzz around artificial intelligences impact on cardiology keeps growing louder, and thats proving to be particularly true in the AI-ECG segment, with 2025 already off to a strong start from ECG startups and researchers alike. AI and ECG pair well due to the strong pattern recognition that machine learning algorithms can achieve.
Signify Research has just released a deep-dive qualitative analysis of developments around the use of AI to analyze and interpret electrocardiograms (ECGs), one of the world’s most ubiquitous diagnostic tests for cardiac disease. Fertile Partnerships Ongoing research partnerships have driven much of recent developments seen in the market.
CMS previously published a New Technology APC (Ambulatory Payment Classifications) code that covers the CardiAMP Cell Therapy investigational study procedure, including the BioCardia investigational products utilized to perform the study procedure, allowing the study centers to be reimbursed for the study procedure and products.
However, despite a strong evidence base, there is insufficient focus on healthcare expenditure and research funding to advance stroke care. 5. Make sure that payment models provide adequate reimbursement of essential and advanced stroke care. 4. Increase the necessary skills in the health workforce.
The data was presented today by Amish Raval , MD, Director of Clinical Cardiovascular Research and Professor of Medicine at the University of Wisconsin-Madison at the Technology and Heart Failure Therapeutics (THT) 2024 annual meeting. The CardiAMP HF II trial is expected to similarly secure CMS reimbursement.
This functionality ensures that cardiology clinics can easily assign the correct codes for procedures and diagnoses, reducing the likelihood of errors and denials that can delay reimbursements and impact revenue. The robust reporting features of EHRs enable extracting relevant data for research studies and clinical trials.
In addition, market research firms, like FACTMR referenced here, focused on the cardiology industry and regularly issue insightful reviews and forecasts worthy of note, portions of each shared here. In addition, 115.9 million adults have prediabetes; 29.3 million have diagnosed diabetes; and 9.7 million have undiagnosed diabetes.**
The CardiAMP clinical development for heart failure is supported by the Maryland Stem Cell Research Fund and is reimbursed by Center for Medicare and Medicaid Services (CMS) for both treatment and control procedures. CAUTION - Limited by United States law to investigational use.
Methods We used data from the Norwegian Control and Payment of Health Reimbursement database to identify all Norwegian residents ≥18 years of age registered with a primary care physician (PCP) in 2019, with onset of AF at ≤50 years of age (early-onset AF) in the period 2006–2019.
To determine if AI-CCTA could hold its own, researchers analyzed CCTA images from 175 patients using Cleerlys AI-QCT ISCHEMIA model and found it outperformed SPECT when compared to invasive angiography. They also add to a growing field of research supporting AI-enhanced CCTA.
We organize all of the trending information in your field so you don't have to. Join thousands of users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content